DE69435048D1 - Systematische evolution von liganden durch exponentielle anreicherung: fotoselektion von nukleinsäureliganden - Google Patents
Systematische evolution von liganden durch exponentielle anreicherung: fotoselektion von nukleinsäureligandenInfo
- Publication number
- DE69435048D1 DE69435048D1 DE69435048T DE69435048T DE69435048D1 DE 69435048 D1 DE69435048 D1 DE 69435048D1 DE 69435048 T DE69435048 T DE 69435048T DE 69435048 T DE69435048 T DE 69435048T DE 69435048 D1 DE69435048 D1 DE 69435048D1
- Authority
- DE
- Germany
- Prior art keywords
- electricites
- photoselection
- ligands
- nucleic acid
- systematic evolution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1048—SELEX
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12393593A | 1993-09-17 | 1993-09-17 | |
US123935 | 1993-09-17 | ||
US14356493A | 1993-10-25 | 1993-10-25 | |
US143564 | 1993-10-25 | ||
PCT/US1994/010562 WO1995008003A1 (en) | 1993-09-17 | 1994-09-16 | Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69435048D1 true DE69435048D1 (de) | 2008-01-03 |
DE69435048T2 DE69435048T2 (de) | 2008-10-02 |
Family
ID=26822045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69435048T Expired - Lifetime DE69435048T2 (de) | 1993-09-17 | 1994-09-16 | Systematische evolution von liganden durch exponentielle anreicherung: fotoselektion von nukleinsäureliganden |
Country Status (6)
Country | Link |
---|---|
EP (2) | EP1889910A3 (de) |
JP (2) | JP3966478B2 (de) |
AU (1) | AU692185B2 (de) |
CA (1) | CA2169535A1 (de) |
DE (1) | DE69435048T2 (de) |
WO (1) | WO1995008003A1 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5705337A (en) * | 1990-06-11 | 1998-01-06 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chemi-SELEX |
US6716580B2 (en) | 1990-06-11 | 2004-04-06 | Somalogic, Inc. | Method for the automated generation of nucleic acid ligands |
EP1741780A3 (de) * | 1995-06-02 | 2007-03-28 | Gilead Sciences, Inc. | Ologonukleotidliganden mit höher Affinität für Wachstumsfaktoren |
US6229002B1 (en) | 1995-06-07 | 2001-05-08 | Nexstar Pharmaceuticlas, Inc. | Platelet derived growth factor (PDGF) nucleic acid ligand complexes |
US6838238B1 (en) * | 1996-10-17 | 2005-01-04 | Invitrogen Corporation | Morphatides: novel shape and structure libraries |
US6242246B1 (en) | 1997-12-15 | 2001-06-05 | Somalogic, Inc. | Nucleic acid ligand diagnostic Biochip |
CA2360748A1 (en) * | 1999-01-19 | 2000-07-27 | Larry Gold | Method and apparatus for the automated generation of nucleic acid ligands |
DE19953854C2 (de) | 1999-11-09 | 2002-01-17 | Max Planck Gesellschaft | Verfahren zur Herstellung von Biopolymeren mit veränderten Eigenschaften |
JP2003088387A (ja) * | 2001-09-19 | 2003-03-25 | Japan Science & Technology Corp | タンパク質からの逆翻訳によるポリヌクレオチド合成方法と、この方法に用いるオリゴヌクレオチド |
EP1481090A4 (de) | 2002-02-15 | 2006-08-09 | Somalogic Inc | Verfahren und reagentien zum nachweis der bindung von zielmolekülen durch nukleinsäureliganden |
US8853376B2 (en) | 2002-11-21 | 2014-10-07 | Archemix Llc | Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
US7803931B2 (en) | 2004-02-12 | 2010-09-28 | Archemix Corp. | Aptamer therapeutics useful in the treatment of complement-related disorders |
US7855054B2 (en) | 2007-01-16 | 2010-12-21 | Somalogic, Inc. | Multiplexed analyses of test samples |
EP2336314A1 (de) * | 2007-07-17 | 2011-06-22 | Somalogic, Inc. | Verbessertes Selex und Photoselex |
US8906700B2 (en) | 2007-11-06 | 2014-12-09 | Ambergen, Inc. | Methods and compositions for phototransfer |
WO2009135198A1 (en) * | 2008-05-02 | 2009-11-05 | Biotex, Inc. | Biomimetic nucleic acids |
DE102012220429A1 (de) | 2012-11-09 | 2014-05-15 | Mahle International Gmbh | Vorheizeinrichtung für eine Kraftstoffeinspritzanlage |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU592560B2 (en) * | 1985-04-22 | 1990-01-18 | Coselco Mimotopes Pty Ltd | Improved method for determining mimotopes |
US5035996A (en) * | 1989-06-01 | 1991-07-30 | Life Technologies, Inc. | Process for controlling contamination of nucleic acid amplification reactions |
ES2259800T3 (es) * | 1990-06-11 | 2006-10-16 | Gilead Sciences, Inc. | Procedimientos de uso de ligandos de acido nucleico. |
AU2580892A (en) * | 1991-09-05 | 1993-04-05 | Isis Pharmaceuticals, Inc. | Determination of oligonucleotides for therapeutics, diagnostics and research reagents |
WO1995007364A1 (en) * | 1993-09-08 | 1995-03-16 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands and improved methods for producing the same |
-
1994
- 1994-09-16 EP EP07016085A patent/EP1889910A3/de not_active Withdrawn
- 1994-09-16 WO PCT/US1994/010562 patent/WO1995008003A1/en active IP Right Grant
- 1994-09-16 EP EP94928621A patent/EP0736105B1/de not_active Expired - Lifetime
- 1994-09-16 JP JP50940195A patent/JP3966478B2/ja not_active Expired - Fee Related
- 1994-09-16 DE DE69435048T patent/DE69435048T2/de not_active Expired - Lifetime
- 1994-09-16 CA CA002169535A patent/CA2169535A1/en not_active Abandoned
- 1994-09-16 AU AU77987/94A patent/AU692185B2/en not_active Ceased
-
2005
- 2005-11-10 JP JP2005325525A patent/JP2006129870A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU7798794A (en) | 1995-04-03 |
WO1995008003A1 (en) | 1995-03-23 |
JP2006129870A (ja) | 2006-05-25 |
EP0736105B1 (de) | 2007-11-21 |
DE69435048T2 (de) | 2008-10-02 |
CA2169535A1 (en) | 1995-03-23 |
EP0736105A1 (de) | 1996-10-09 |
AU692185B2 (en) | 1998-06-04 |
JPH09502616A (ja) | 1997-03-18 |
EP0736105A4 (de) | 1998-10-28 |
EP1889910A2 (de) | 2008-02-20 |
EP1889910A3 (de) | 2009-09-02 |
JP3966478B2 (ja) | 2007-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69435048D1 (de) | Systematische evolution von liganden durch exponentielle anreicherung: fotoselektion von nukleinsäureliganden | |
AT399720B (de) | Gewinnung von amphiregulin durch gentechnische verfahren | |
ATE151433T1 (de) | Verfahren und kit zur reinigung von nukleinsäure | |
DE69426956D1 (de) | Nachweis von Mycobakterien durch Nukleinsäure-Multiplexamplifizierung | |
DK0739356T3 (da) | Polyklonalt antistof mod PNA/nukleinsyre-komplekser | |
DE69434942D1 (de) | Mehrzweckreagenzsystem zur schnellen lysierung von vollblutproben | |
DE3671263D1 (de) | Bauelementensatz zur errichtung von bauwerken. | |
DE3584613D1 (de) | Ziegelpaneel. | |
DE3582870D1 (de) | Verfahren zur herstellung von deuteriertem methylacrylat oder methylmethacrylat. | |
DE3887957D1 (de) | Mischung zur Absorption von sauren Gasen. | |
DE3670284D1 (de) | Verfahren zur karbonylierung von ethylenisch ungesaettigten verbindungen. | |
DE3577546D1 (de) | Herstellungsverfahren von methylmethacrylaten. | |
IT8719501A0 (it) | Quantificazione di molecole di acido nucleico e il kit reattivo impiegato. | |
ATA66988A (de) | Verfahren zur herstellung von als baumaterialien verwendbaren granulaten aus insbes. haushaltsabfaellen | |
DE3671918D1 (de) | Nukleinsaeure sequenzanalyse durch hemmung von exonuklease. | |
DE3482995D1 (de) | Nukleinsaeure-hybridisierungstest mittels antikoerper gegen einschaltungskomplexe. | |
ATE90508T1 (de) | Verwendung von di-styryl-phenyl-triglykolether als kristallisationsinhibitor. | |
DE68906562T2 (de) | Verfahren zur Kristallisierung von Bisphenol-A-phenol-Addukt. | |
DE3874107D1 (de) | Reinigung von essigsaeure durch behandeln mit ozon. | |
DE69121456T2 (de) | Stabilisiertes Harnsäurereagens | |
DE3862647D1 (de) | Verfahren zur durchmischung von schuettguetern. | |
DE69030804T2 (de) | Reagenzien zur verbesserung von hybridisierung | |
DE69231178D1 (de) | Nukleinsäure-amplifikation durch polymerase-reaktion | |
DE68910024D1 (de) | Verfahren zur Herstellung von Methacrylsäure. | |
DE3874667T2 (de) | Verfahren zur reinigung von methacrylsaeure. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |